主成分略述：2-Deoxy-2-[18F]fluoro-D-glucose
適應症：肺癌、大腸癌、淋巴癌、黑色素瘤、冠心病、癲癇之偵測
在臨床上已有多種原發性腫瘤癌症，使用非侵入式的分子影像診斷，得到相當好的結果，即使在病灶早期，透過氟18之氟化去氧葡萄糖（F-18 FDG)，偵測人體內細胞代謝葡萄糖的情形，經過分子影像技術，讓醫師正確診斷。
Non-invasive radiopharmaceutical imaging has been widely used during clinical management for numerous cancers and plays an essential role while achieving remarkable clinical outcomes. Even in the early stages of some diseases, F-18 FDG is able to detect the status of glucose metabolism in the cells through molecular imaging technology, allowing physicians to conduct the most appropriate disease management.
普瑞默致力於以放射配體診療藥物技術(RLT)推動癌症治療的進步。我們相信，RLT 技術能夠促進更寬廣的治療窗口，並提供比現有治療選項更安全、更有效的治療
